Our Experts

At NDA we’re a team of experts – experts in the regulated disciplines, and experts in drug development.

Some of us have attained our experience from working inside regulatory authorities, carefully assessing the benefits and risks of new treatments. Some of us have worked for years in the biotech and pharmaceutical industry, patiently developing life changing products for patients suffering from debilitating and sometimes deadly diseases and conditions.

Whatever our background, we share a passion for the art and science of drug development and for making a difference to the clients and the patients we ultimately serve.

Get to know the people behind the passion – read more about our incredible team below.


Amy Blawas

Senior Consultant
Expert in advanced therapies and regulatory strategy

Dr Arno Kromminga

Advisory Board Member
Expert in immunogenicity and regulated bioanalysis

Dr Björn Carlsson

Principal Consultant
Expert in non-clinical development and ATMPs

Dr Kurt Stoeckli

Advisory Board President
Expert in biopharmaceutical R&D strategy and operational management

Dr Niamh Kinsella

VP Early Stage Development
Expert in global strategic CMC and regulatory development

Dr Paula Salmikangas

Advisory Board Director
Expert in biological medicinal products

Dr Steffen Thirstrup

Advisory Board Director
Expert in EU regulatory system and clinical/regulatory strategies

Professor Beatriz Silva Lima

Advisory Board Member
Expert in non-clinical safety strategies

Contact Us

Your drug development needs are unique

Contact us to learn how our experts can support you to meet all regulatory, quality and safety requirements and ensure the best path to approval.

Let's Bring Medicines to the World